NCT04804514View on ClinicalTrials.gov

Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 14, 2021

Primary Completion Date

March 3, 2023

Study Completion Date

March 3, 2023

Conditions
Dentin Sensitivity
Interventions
DRUG

KH001

The study drug is applied to teeth

DRUG

Placebo

The placebo is applied to teeth

Trial Locations (1)

Unknown

Seoul National University Dental Hospital, Seoul

All Listed Sponsors
lead

HysensBio Co., Ltd

INDUSTRY